SEMHF - Siemens Healthineers: Good Return Long-Term Potential Intact

2024-03-11 01:30:26 ET

Summary

• Siemens Healthineers has seen a 7.5% increase in its stock price since the last article and has a solid upside potential.
• The company's recent results show strong revenue growth, margin improvements, and successful contract wins.
• While the valuation of the company has increased, it still presents a potential double-digit annualized return for investors.

Dear readers/followers,

Siemens Healthineers ( OTCPK:SEMHF ) ( OTCPK:SMMNY ) is just as solid a business as I wrote about in my last article, which by the way you can find here. That article is from back in December, which makes this an update roughly after 3 months. What we have since then are fresh results, fresh RoR, and a new look at the company at almost 10% higher than before.

Unless you're new to my coverage of this company, you'll know that I consider Siemens Healthineers to be a very solid medtech company with great upside. Now, finding investment quality here is not as easy as in other companies or theses, but it's also not impossible - and I consider Siemens Healthineers to be a company that is not only worth looking closely at but worth considering an investment into....

For further details see: